As the COVID-19 federal public health emergency and its subsequent pandemic restrictions are set to end in May 2023, the future of telemedicine prescribing has become a central question for many physicians and consumers.
Update on Federal and State Developments: Regulation of Financial Interactions between Health Care Providers and Pharmaceutical and Medical Device Companies